It also should not be combined with other so-called GLP-1 receptor agonist drugs, which include its sibling Mounjaro, as well as Wegovy and Ozempic
Researchers are also looking into possible problems like pancreatitis, gallbladder issues, thyroid tumors, hypoglycemia, kidney failure, and vision changes
And for day-to-day support, Noom can help you create a plan that combines food tracking, exercise tips, and daily lessons to maintain weight loss for the long term
With the market projected to grow in the coming years, driven by the increasing prevalence of these conditions, pharmaceutical companies have been investing heavily in developing and marketing GLP-1 agonists
Active&Fit is a federally registered trademark of ASH
Zhihong Y, Chen W, Qianqian Z, Lidan S, Qiang Z, Jing H, et al